跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 96,806 条关于
“endometrioid ovarian cancer”
全部
96,806
临床试验
78,642
药物
2,303
机构
1,106
资讯
14,755
6年前
PARP Inhibitors in Frontline Ovarian Cancer Treatment: A Review of Clinical Trials
去年
Niraparib Maintenance Shows Sustained Progression-Free Survival Benefit in Advanced Ovarian Cancer, But No Overall Survival Improvement
2年前
Rinatabart Sesutecan Shows Promise in Heavily Pretreated Ovarian Cancer
2年前
Rinatabart Sesutecan Shows Promise in Heavily Pretreated Ovarian Cancer
去年
HIPEC Plus Surgery Improves Survival in Recurrent Ovarian Cancer
11个月前
Theolytics Advances Novel Oncolytic Immunotherapy THEO-260 in Phase I/IIa Ovarian Cancer Trial
6个月前
Theolytics Secures €8 Million EU Grant to Advance Novel Oncolytic Immunotherapy for Platinum-Resistant Ovarian Cancer
去年
Anetumab Ravtansine Plus Bevacizumab Falls Short Against Standard Therapy in Ovarian Cancer Trial
去年
Dana-Farber Launches First Clinical Trial of Memory-Like Natural Killer Cells in Ovarian Cancer
去年
Novel CAR T-Cell Therapy Trial Advances to Third Cohort in Ovarian Cancer
第 1 页，共 1476 页
上一页
下一页
